Gene expression levels of CPT1A and SREBP-1c remained higher than in NW subjects during the whole intervention period, suggesting that they reflect deeper alterations in humans with overweight and obesity, which are not easily recovered by body fat loss. Here, SREBF1 is linked to obesity disorder.